Merck LiteSpark-001: Advanced rCC progression after immunotherapy
Research Grant
Awarded By
Merck Sharp & Dohme
Start Date
July 28, 2022
End Date
October 10, 2023
Awarded By
Merck Sharp & Dohme
Start Date
July 28, 2022
End Date
October 10, 2023